Research article
Medwave 2019;19(4):e7631 doi: 10.5867/medwave.2019.04.7631

National trends in prevalence and mortality rates of thyroid cancer using data from the Ministry of Health of Peru

Noé Atamari-Anahui, Luz Morales-Concha, Ana Gabriela Moncada-Arias, Abraham De-los-Ríos-Pinto, Yerika Huamanvilca-Yépez, César Johan Pereira-Victorio, Evelina Andrea Rondón-Abuhadba, Marco Edmundo Ordoñez-Linares

Abstract

Introduction
The incidence of thyroid cancer has increased worldwide. Peru has few reports describing the national and regional epidemiology of thyroid cancer.

Objective
The incidence of thyroid cancer has increased worldwide. Peru has few reports describing the national and regional epidemiology of thyroid cancer.

Methods
A descriptive study of trends was conducted with secondary data obtained from a public information source in Peru. The ICD 10: C73.0 coding record was evaluated, by age group, year and region. The age-standardized prevalence (period 2005 to 2016) and mortality (period 2005 to 2015) were calculated by region and year of study.

Results
In the 2005-2016 period, 19 513 cases of thyroid cancer were recorded. The age group with the highest frequency was 30 to 59 years (57.7%). The prevalence increased from 4.7 to 15.2 cases per 100 000 inhabitants in the period 2005-2016, with the coastal region showing the greatest increase. Likewise, 1596 deaths from thyroid cancer (period 2005 to 2015) were recorded, more frequently in those older than 60 years (75.5%). The age-standardized mortality rate increased from 0.67 in 2005 to 0.72 in 2015, being the highlands the one with the greatest increase.

Conclusions
The prevalence of thyroid cancer increased and mortality remained constant in the period studied. These results suggest exploring social and population factors that may have influenced these results. Likewise, population records of this and other neoplasms in Peru should be improved.


 

Only the Spanish version is available.

 


Referencias
  1. Xu B, Ghossein R. Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management. Eur J Surg Oncol. 2018 Mar;44(3):338-347. | CrossRef | PubMed |
  2. La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer. 2015 May 1;136(9):2187-95. | CrossRef | PubMed |
  3. Sierra MS, Soerjomataram I, Forman D. Thyroid cancer burden in Central and South America. Cancer Epidemiol. 2016 Sep;44 Suppl 1:S150-S157. | CrossRef | PubMed |
  4. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. | CrossRef | PubMed |
  5. Hall SF, Irish J, Groome P, Griffiths R. Access, excess, and overdiagnosis: the case for thyroid cancer. Cancer Med. 2014 Feb;3(1):154-61. | CrossRef | PubMed |
  6. Morris LG, Sikora AG, Tosteson TD, Davies L. The increasing incidence of thyroid cancer: the influence of access to care. Thyroid. 2013 Jul;23(7):885-91. | CrossRef | PubMed |
  7. Udelsman R, Zhang Y. The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds. Thyroid. 2014 Mar;24(3):472-9. | CrossRef | PubMed |
  8. Gallagher EJ, LeRoith D. Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality. Physiol Rev. 2015 Jul;95(3):727-48. | CrossRef | PubMed |
  9. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst. 2010 May 5;102(9):605-13. | CrossRef | PubMed |
  10. Takano T. Natural history of thyroid cancer [Review]. Endocr J. 2017 Mar 31;64(3):237-244. | CrossRef | PubMed |
  11. Ramos Muñoz W, Venegas Ojeda D, Medina Osis J, Guerrero León P, Cruz Martínez A. Análisis de la situación del cáncer en el Perú, 2013. Lima-Perú: Ministerio de Salud del Perú; 2013. | Link |
  12. Boltz MM, Hollenbeak CS, Schaefer E, Goldenberg D, Saunders BD. Attributable costs of differentiated thyroid cancer in the elderly Medicare population. Surgery. 2013 Dec;154(6):1363-9; discussion 1369-70. | CrossRef | PubMed |
  13. Lubitz CC, Kong CY, McMahon PM, Daniels GH, Chen Y, Economopoulos KP, et al. Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer. 2014 May 1;120(9):1345-52. | CrossRef |
  14. Ministerio de Salud del Perú. Guía técnica para el correcto llenado del certificado de defunción. Lima: MINSA; 2017:30. | Link |
  15. Oficina General de Estadística e Informática. Manual para el llenado del formulario de defunción. Lima: Oficina General de Estadística e Informática; 2009. [on line] | Link |
  16. Lazo-Gonzales O, Alcalde-Rabanal J, Espinosa-Henao O. El sistema de salud en Perú: Situación y desafíos. Lima: Colegio Médico del Perú: REP; 2016;47. | Link |
  17. Ahmad O, Boschi-Pinto C, Lopez A, Murray C, Lozano R, Inoue M. Age standardization of rates: a new WHO standard. Geneva Switzerland: WHO; 2000:14
  18. Instituto Nacional de Estadística e Informática. Distribución de la Población por Departamentos Lima: INEI; 2015. [on line] | Link |
  19. Sarria-Bardales G, Limache-García A. [Cancer control in Peru: a comprehensive approach to a public health issue]. Rev Peru Med Exp Salud Publica. 2013 Mar;30(1):93-8. | CrossRef | PubMed |
  20. Marzo-Castillejo M, Vela-Vallespín C. [Overdiagnosis in cancer]. Aten Primaria. 2018 Nov;50 Suppl 2:51-56. | CrossRef | PubMed |
  21. Kitahara CM, Sosa JA. The changing incidence of thyroid cancer. Nat Rev Endocrinol. 2016 Nov;12(11):646-653. | CrossRef | PubMed |
  22. Sánchez-Moreno F. [The national health system in Peru]. Rev Peru Med Exp Salud Publica. 2014 Oct-Dec;31(4):747-53. | PubMed |
  23. Leenhardt L, Bernier MO, Boin-Pineau MH, Conte Devolx B, Maréchaud R, Niccoli-Sire P, et al. Advances in diagnostic practices affect thyroid cancer incidence in France. Eur J Endocrinol. 2004 Feb;150(2):133-9. | CrossRef | PubMed |
  24. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ. 2013 Aug 27;347:f4706. | CrossRef | PubMed |
  25. Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013. JAMA. 2017 Apr 4;317(13):1338-1348. | CrossRef | PubMed |
  26. Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N Engl J Med. 2016 Aug 18;375(7):614-7. | CrossRef | PubMed |
  27. Ahn HS, Welch HG. South Korea’s Thyroid-Cancer “Epidemic” — Turning the Tide. N Engl J Med. 2015;373(24):2389-90. | CrossRef | PubMed |
  28. Atamari-Anahui N, Ccorahua-Rios MS, Taype-Rondan A, Mejia CR. Mortalidad atribuida a diabetes mellitus registrada en el Ministerio de Salud de Perú, 2005-2014. Rev Panam Salud Pública. 2018;42:e50. | CrossRef |
  29. Herrera-Añazco P, Atamari-Anahui N, Flores-Benites V. Número de nefrólogos, servicios de hemodiálisis y tendencia de la prevalencia de enfermedad renal crónica en el Ministerio de Salud de Perú. Rev Peru Med Exp Salud Pública. 2019;36(1):62-7. | CrossRef |

 

Licencia Creative Commons Esta obra de Medwave está bajo una licencia Creative Commons Atribución-NoComercial 3.0 Unported. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.
Address: Villaseca 21, Of. 702, Ñuñoa, Santiago de Chile.
Phone: 56-2-22743013
ISSN 0717-6384